+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Jazz Pharmaceuticals

JAZZNASDAQ

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$108.46

-0.55-0.50%

Last update: 1:22 PM

15 minutes delayed

Q2 2024 Earnings in 9 days from now on Wed Jul 31st, after the market close

Jazz Pharmaceuticals (JAZZ) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest news for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock

Jazz Pharmaceuticals Stock (NASDAQ: JAZZ)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, July 15, 2024

How Is The Market Feeling About Jazz Pharmaceuticals?
Benzinga Insights

Friday, July 12, 2024

Morgan Stanley Maintains Equal-Weight on Jazz...
Benzinga Newsdesk

Thursday, July 11, 2024

Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US
Nicolás Jose Rodriguez
Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country
Jelena Martinovic

Tuesday, July 02, 2024

Assessing Jazz Pharmaceuticals: Insights From 7 Financial Analysts
Benzinga Insights
UBS Maintains Neutral on Jazz Pharmaceuticals...
Benzinga Newsdesk

Thursday, June 20, 2024

Why Is Jazz Pharmaceuticals Stock Trading Lower On Thursday?
Vandana Singh
Needham Maintains Buy on Jazz Pharmaceuticals...
Benzinga Newsdesk
Jazz Pharmaceuticals' Suvecaltamide (JZP385) ...
Benzinga Newsdesk

Wednesday, June 05, 2024

This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Avi Kapoor
Decoding 12 Analyst Evaluations For Jazz Pharmaceuticals
Benzinga Insights
Goldman Sachs Initiates Coverage On Jazz Phar...
Benzinga Newsdesk

Monday, June 03, 2024

Reported Saturday, Jazz Pharmaceuticals Showc...
Benzinga Newsdesk

Wednesday, May 29, 2024

Jazz Pharma's Zanidatamab Granted FDA Priorit...
Benzinga Newsdesk

Wednesday, May 22, 2024

Jazz Pharmaceuticals And Life Science Cares C...
Benzinga Newsdesk

Saturday, May 18, 2024

Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
Nicolás Jose Rodriguez

Wednesday, May 15, 2024

10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights

Tuesday, May 14, 2024

Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Nicolás Jose Rodriguez

Wednesday, May 08, 2024

Neena M Patil Implements A Sell Strategy: Offloads $548K In Jazz Pharmaceuticals Stock
Benzinga Insights

Friday, May 03, 2024

HC Wainwright & Co. Reiterates Buy on Jazz Ph...
Benzinga Newsdesk
Barclays Maintains Overweight on Jazz Pharmac...
Benzinga Newsdesk

Thursday, May 02, 2024

Demystifying Jazz Pharmaceuticals: Insights From 15 Analyst Reviews
Benzinga Insights
Needham Reiterates Buy on Jazz Pharmaceutical...
Benzinga Newsdesk

Wednesday, May 01, 2024

Jazz Pharmaceuticals Affirms 2024 Revenue Gui...
Benzinga Newsdesk
Jazz Pharmaceuticals Q1 2024 Adj EPS $2.68 Mi...
Benzinga Newsdesk

Wednesday, April 10, 2024

Breaking Down Jazz Pharmaceuticals: 15 Analysts Share Their Views
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk

Tuesday, April 02, 2024

CORRECTION: Jazz Pharmaceuticals Completes Za...
Benzinga Newsdesk

Monday, March 25, 2024

How To Make Your Cannabis Business More Attractive For Investors In 2024: Advice On Financial Health & Innovation
Nina Zdinjak

Friday, March 22, 2024

Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk

Wednesday, March 20, 2024

Truist Securities Reiterates Buy on Jazz Phar...
Benzinga Newsdesk
The Analyst Landscape: 12 Takes On Jazz Pharmaceuticals
Benzinga Insights
Piper Sandler Reiterates Overweight on Jazz P...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Jazz Ph...
Benzinga Newsdesk
Needham Reiterates Buy on Jazz Pharmaceutical...
Benzinga Newsdesk

Friday, March 15, 2024

Stifel Maintains Buy on Jazz Pharmaceuticals,...
Benzinga Newsdesk

Thursday, March 14, 2024

HC Wainwright & Co. Maintains Buy Rating for Jazz Pharmaceuticals: Here's What You Need To Know
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Jazz Pha...
Benzinga Newsdesk

Tuesday, March 12, 2024

Time Is Still The Enemy, Says Mom Who Moved Mountains For Her Epileptic Daughter & Still Advocates For Millions Of CBD Users
Nina Zdinjak

Monday, March 04, 2024

CORRECTION: Jury Ruled In Favor Of Avadel Wit...
Benzinga Newsdesk
Avadel Pharmaceuticals Issues Statement On Pa...
Benzinga Newsdesk

Thursday, February 29, 2024

Cantor Fitzgerald Reiterates Overweight on Ja...
Benzinga Newsdesk
RBC Capital Reiterates Outperform on Jazz Pha...
Benzinga Newsdesk
JP Morgan Maintains Overweight on Jazz Pharma...
Benzinga Newsdesk
Demystifying Jazz Pharmaceuticals: Insights From 4 Analyst Reviews
Benzinga Insights
Needham Maintains Buy on Jazz Pharmaceuticals...
Benzinga Newsdesk

Wednesday, February 28, 2024

Jazz Pharmaceuticals Sees FY24 Adj. EPS $18.1...
Benzinga Newsdesk
Recap: Jazz Pharmaceuticals Q4 Earnings
Benzinga Insights
Jazz Pharmaceuticals Q4 2023 Adj EPS $5.02 Mi...
Benzinga Newsdesk
Earnings Scheduled For February 28, 2024
Benzinga Insights

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved